Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely

Learn more about:
Related Clinical Trial
Colorado-Oregon Altitude Study The Effects of Intermittent Hypoxia on Acute Hypoxic Injury Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude The Pre-acclimatization Augmented Extreme Altitude Expedition Effect of Altitude on Iron Absorption in Iron Depleted Women Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD HIGH Altitude CArdiovascular REsearch Latin America Population Study Effect of Acetazolamide on Sleep Disordered Breathing in Lowlanders Older Than 40 Years at Altitude Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude. Effect of Acetazolamide on Lung Water Content by Ultrasound in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Right Heart Function During Exercise in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Visuo-motor Learning in Lowlanders Older Than 40 Years at Altitude Effect of Acetazolamide on Maximal Exercise Performance in Lowlanders Older Than 40 Years at Altitude Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance Iron Status and Cardiopulmonary Physiology Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders Older Than 40 Years at Altitude. Effect of Acetazolamide on Postural Control in Lowlanders Older Than 40 Years at Altitude Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude The Psychophysiological Effect of Simulated and Terrestrial Altitude Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude AZ, MZ, and the Pulmonary System Response to Hypoxia Study of the Effects of Iron Levels on the Lungs at High Altitude Effects of Aircraft Cabin Altitude on Passenger Comfort and Discomfort Three New Ideas to Protect Special Forces From the Stress of High Altitude Breathing Training to Improve Human Performance at High Altitude Oxidative Stress in Hypobaric Hypoxia Safety Evaluation of Aminophylline and Methazolamide Decompression Tables for Diving at Altitude Chronic Mountain Sickness, Systemic Vascular Function Evaluation of the Prevention and Treatment Effects of Chinese Medicine on High Altitude Illness Inhaled Budesonide for Altitude Illness Prevention Sickness Evaluation at Altitude With Acetazolamide at Relative Doses Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) Spectroscopic and Diffusion Weighted Analysis of the Effects of Dexamethasone on High Altitude Cerebral Oedema (HACE) Drug Combination on Exercise Performance at High Altitude Acclimatization Mechanisms During Ascent to 7500m Prevention of Acute Mountain Sickness by Intermittent Hypoxia Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages Study Looking at End Expiratory Pressure for Altitude Illness Decrease (SLEEP-AID) Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Comparison of Metoclopramide and Ibuprofen for the Treatment of Acute Mountain Sickness A Trial of Acetazolamide Versus Placebo in Preventing Mountain Sickness During Rapid Ascent Training in Hypoxia to Prevent Acute Mountain Sickness Study of Compound Danshen Dripping Pills to Treat Acute Mountain Sickness Altitude Sickness Prevention With Ibuprofen Relative to Acetazolamide and Treatment Efficacy Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness Inhaled Budesonide and Acute Mountain Sickness Altitude Sickness Prevention and Efficacy of Comparative Treatments Alternative Treatments in Acute Mountain Sickness Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Brief Title

Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely

Official Title

Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely

Brief Summary

      This project will consist of two studies, each investigating resting and exercise
      cardio-respiratory responses during exposure to hypoxia in individuals born prematurely and
      individuals born at full term of two different age groups: Kids (10-14 yrs) and Adults (18-22
      yrs).Additional study will be performed on a preterm adult cohort (15 participants) that will
      investigate potential differences between hypobaric and normobaric hypoxia as outlined in the
      following section.
    

Detailed Description

      The study protocol in each age group will comprise two visits to the laboratory testing
      sessions in a randomized order. On one occasion the participants will perform a resting
      hypoxia test and a graded exercise test to voluntary exhaustion in normoxic condition ((NORM;
      fraction of inspired oxygen (FiO2)=0.209, placebo). On a second visit the participants will
      perform a hypoxia sensitivity test and a graded exercise test to voluntary exhaustion in
      hypoxic condition (HYPO; FiO2=0.120 corresponding to terrestrial altitude of approx. 4000 m).
      Indirect calorimetry, near infrared spectroscopy and ECG measurements will be performed
      throughout all tests. During both testing sessions the participants will also undergo
      anthropometry measurements and pulmonary function testing. The outline of the research visits
      is presented in the bellow figure:
    


Study Type

Interventional


Primary Outcome

Tolerance to hypoxia during rest and exercise in preterm and full term individuals

Secondary Outcome

 Oxidative stress responses to hypoxic exercise in preterm and full term

Condition

Hypoxia

Intervention

Graded exercise testing

Study Arms / Comparison Groups

 Hypoxia at rest and exercise
Description:  The participants will perform a resting test, hypoxia sensitivity test and a graded exercise test to voluntary exhaustion in normoxic condition ((HYPO; FiO2=0.120 corresponding to terrestrial altitude of approx. 4000 m)

Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information


Recruitment Status

Other

Estimated Enrollment

37

Start Date

April 2016

Completion Date

December 2018

Primary Completion Date

October 2016

Eligibility Criteria

        Inclusion Criteria:

        Healthy male individuals

        PRETERM group; gestational age: ≤ 32 weeks; gestational weight ≤ 1500 g

        CONTROL group: full term born individuals ≤ 38 weeks

        Exclusion Criteria:

        Medication required that may interfere with the interpretation of the results

        Chronically illnesses

        Hormonal therapy

        Recent sub-standard nutritional status

        Family history of respiratiory, cardio-vascular, renal or hematological disease History of:
        thyroid dysfunction, renal stones, diabetes, allergies, hypertension, hypocalcaemia, uric
        acidaemia, lipidaemia or hyperhomocystinaemia

        History of mental illness

        Smoker within six months prior to the start of the study

        Abuse of drugs, medicine or alcohol

        Participation in another study up to two months before study onset

        No signed consent form before the onset of the experiment

        Blood donors in the past three months before the onset of the experiment

        Vegetarian and Vegans

        Migraines

        History of vestibular disorders

        Claustrophobia
      

Gender

Male

Ages

18 Years - 24 Years

Accepts Healthy Volunteers

Accepts Healthy Volunteers

Contacts

Damjan Osredkar, MD, PhD, +38615229273, [email protected]

Location Countries

Slovenia

Location Countries

Slovenia

Administrative Informations


NCT ID

NCT02780908

Organization ID

JozefSI


Responsible Party

Sponsor

Study Sponsor

Jozef Stefan Institute

Collaborators

 University of Ljubljana School of Medicine, Slovenia

Study Sponsor

Damjan Osredkar, MD, PhD, Principal Investigator, University Children's Hospital Ljubljana Department of Pediatric Neurology


Verification Date

August 2016